Exam 2 Material Flashcards

1
Q

Somatic Nervous System vs Autonomic Nervous System

What do the control? Subdivisions?

A

Somatic: Consciously controlled functions that deal with movement, respiration, and posture

ANS: Largely independent system. Concerned with control and integration of visceral functions necessary for life such as cardiac output, blood flow distribution, and digestion.
1. Sympathetic
2. Parasympathetic
3. Enteric- “gut feeling”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SNS

Fight or Flight

A

“Fight or flight” or “Ergotrophic” is a sympathetic nervous system response. HR is increased, BP increased, pupillary constriction, up to 75% of blood is shunted to our skeletal muscles. We start to sweat, and our bronchioles dilate. There has to be a continuous stimulus to elicit this response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PNS

Rest and Digest

A

“Rest-and-digest” or “Trophotropic” Is a parasympathetic nervous system response. It lowers our HR back down to baseline, contricts our bronchioles (bad for asthmatics), shunts blood to systems such as endocrine, GI. Concerned with conserving energy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SNS

Anatomy, Primary Neurotransmitter

A

-Arise from the CNS at the level of the T-Spine (T1-L2) or Thoracolumbar spine
-The sympathetic chain is a collection of cells called ganglia that receive information and deliver it to their target organ
-Short preganglionic fibers originate in the chain ganglia at the level of the spine
-Long post-ganglionic fibers that innervate and terminate at their target organ
-Primary neurotransmitter is norepinephrine (adrenergic)
-Adrenal glands will also release epinephrine

ALL PREGANGLIONIC NEURONS RELEASE ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PNS

Anatomy, Primary neurotransmitter

A

-Nerves located in the craniosacral area (Cranial nerves except II)
-Long preganglionic fibers. Leave the CNS through the cranial nerves and sacral spinal roots
-Short postganglionic fibers, terminate on the target organ
-Ganglia are located in visceral organs
-Most important cranial nerve here is X (Vagus)
-> 75% of the PNS output goes through the vagus nerve
-Primary neurotransmitter is ACh (cholinergic)

ALL PREGANGLIONIC NEURONS RELEASE ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sympathomimetics

Direct acting vs indirect. What do these drugs do?

A

-Drug class that mimics the SNS
-Direct acting drugs: Epinephrine, isoproteronol, albuterol
-Indirect acting drugs: Ephedrine and amphetamines
-> Release stored NE, block reuptake or reverse the NET (transporter)
-Constricts blood vessels, inotropic & chronotropic cardiac effects, decrease bronchiole tone, decrease uterine tone (preterm labor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Also sympathoplegics

Sympatholytics

what do these drugs do?

A

-Inhibit the SNS
-Alpha blockers: Phentolamine
-Beta blockers: Propanolol
-non-specific blockers: Labetalol
-Decrease BP, HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Autonomic Receptors

Adrenergic Receptors

Receptors and Locations

A

A1: Usually vascular smooth muscle
A2: Presynaptic adrenergic nerve terminals, smooth
B1: Heart, brain
B2: Smooth muscle in lungs, cardiac muscle
D1-D5: Brain
D4: Brain and CV systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholinergic Receptors

Muscarinic vs Nicotinic

Locations. Excitatory or inhibitory?

A

Muscarinic:
M1- (E) CNS neurons, SNS postganglionic neurons
M2-(I) Myocardium, smooth muscle, CNS
M3- (E) Exocrine glands, vessels, CNS
M4- (I) CNS, vagal nerve endings
M5- (E) Vascular endotheliam (esp. cerebral vessels), CNS

M2, M4: Inhibitory
M1, M3, M5: Excitatory

Nicotinic:
Nn: Neuronal; postganglionic neurons
Nm: Muscular; skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Adrenoreceptors

A1

Receptor pathway, effects on CV system

A

-Gq Receptor Pathway
Activates phospholipase C–> cleaves PIP2 into IP3 & DAG–> IP3 stimulates release of Ca++ into cytosol–> increased levels of myosin light chain kinase
DAG + Ca++ –> activate protein kinase C–> inhibits myosin light chain phosphatase

-SNS activation: results in muscle contraction of vascular smooth muscle; however, decreases CO due to increased PVR. Can have reflex bradycardia initially

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Adrenoreceptors

A2

A

GI pathway: Inhibits adenlyl cyclase –> less cAMP is formed–> usually means less Ca++ influx into the cell, less K+ out of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Adrenoreceptors

B1 & B2

Receptor Pathway, Effects on CV & Respiratory System

A

GS Pathway: Stimulates adenylate cyclase–> causing an increase in cAMP (major second messenger in B receptor activation)–> increase in Ca++ influx

-SNS activation in heart: Increases contractility and chronotropy
-SNS activation in skeletal blood vessels (B2): Relax
-In bronchiolar smooth muscle (B2): Relax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Autonomic Feedback Loop, Increase & Decrease in BP

Cardiovascular Feedback Loops

A

Mean arterial pressure is sensed by the baroreceptors (carotid and aortic arch)
Increase in BP: Brainstem activates PNS –> ACh released to slow down HR and decrease cardiac output

Decrease in BP: Brainstem activates SNS –> NE binds to B1 in the heart –> increasing HR & CO
NE binds to A1 receptors in peripheral vascular system –> constriction, increasing blood return to the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hormonal Feedback Loop

Cardiovascular Feedback Loop

A

-Renal BP decreases–> renin released–> angiotensinogen converted to angiotensin 2–> causes constriction
Aldosterone released–> Decrease UOP, Increase H20 retention –> increased blood volume, increased venous return, increased CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Six Types of Neurotransmitters

A
  1. Esters; ACh
  2. Monoamines; NE, serotonin, dopamine
  3. Amino Acids; GABA, glutamate
  4. Purines; Adenosine, ATP
  5. Peptides; Substance P, Endorphins
  6. Inorganic gases; Nitric Oxide (released by presynaptic cell)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Three of them

Types of Synapses

A
  1. Chemical: Release neurotransmitters
  2. Electrical: Gap junctions between adjacent cells (ions)
  3. En Passant Synapses: IDK what these do
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What happens to them? (4)

Neurotransmitter Fate

A
  1. Diffuse away from the synapse
  2. Degraded by enzymes (ACh-esterase)
  3. Re-uptake into the presynaptic cell
  4. Uptake into the surrounding cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Excitatory vs Inhibitory Pathway

A

Ion channel opens –> increased PNa+ –> depolarization occurs–> Excitation

Ion channel opens–> increasd PCl- –> hyperpolarization of the cell –> inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Function of 3 Neurotransmitters Dealing w/ Emotion

A
  1. NE: Plays a role in fear, anger, distress
  2. Serotonin: Low levels implicate depression
  3. Dopamine: Rewarding, pleasurable (addiction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Formation, Transport, Enzymatic Cleavage of ACh

A

Synthesized in the cytoplasm of releasing cell from Acetyl-CoA (mitochrondria provide) and choline (from diet)
Acetyl-CoA + Choline + Choline acetyltransferase (ChAT) forms ACh

Transported into vesicles by VAT ( ~50,000 per vesicle)

Acetylcholinesterase breaks down ACh: Binds to the ester, causes tension, breaks down into acetic acid and choline

CHT- Choline transporter back into neuron. Co-transportor of Na+ and choline. Facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Release of ACh into synapse

Cholingeric Transmission (ACh)

A
  1. Action potential generated from axon hillock –> Synaptic bouton
  2. Triggers P-type Ca++ Channel, Ca++ influx into cell
  3. Ca++ Destabilizes the VP-2 vesicles
  4. Fusion of VP-2 vesicles with terminal membrane
  5. Exocytosis of ACh into synaptic cleft
  6. ACh binds to nACh-r –> broken down by AChE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Docking Molecules, Fusion molecule

Anchoring ACh Near Synapse

A

Snare complex is used to anchor VP-2 vesicles near the release site
-Syntaxin, SNAP-25, VAMP are all proteins associated with the Snare complex

-Synaptotagmin: Responds to the Ca++ influx into the cell and facilitates vesicle fusion with the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Presynaptic Receptors

Heteroreceptor vs Autoreceptor

A

-Receptors on the presynaptic neuron.
-Autoreceptor refers to a receptor that responds to the neurotransmitter being release by that neuron
-Heteroreceptor will respond to a different neurotransmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Synthesis,Transport, Storage, Release & Degradation of NE

A

-Derived from amino acid tyrosine
-Tyrosine is converted into dopamine (tyrosine & tyrosine hydroxylase –> Dopa & dopadecarboxylase –> Dopamine)
-After conversion to dopamine, dopamine is transported into the vesicle VMAT. Dopamine is converted into NE, inside the vesicle, by dopamine-b- hydroxylase & ATP
-Release of NE happens when an action potential opens voltage sensitive Ca++ channels –> increasing intracellular Ca+
-After release, NE diffuses out of the cleft or is transported by NET back into the cytoplasm. If transported back into cytoplasm, it is reused OR degraded by MAO
This mechanism can be blocked by cocaine or certain antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Effects of Cholinomimetics in Major Organ Systems

Eye, CV, GI, Resp, CNS, NMJ

A

Eye:
-Muscarinic agonists cause contraction of the pupil
-increase intraocular drainage

CV:
-Reduction in PVR
-Vasodilation, reflex tachycardia. Large doses: bradycardia

Respiratory:
-Bronchiole smooth muscle contracts
-Tracheobronchial secretions increased

GI:
-Increased motility
-Salivary & gastric glands stimulated
-Sphincters relax

CNS:
-Primarily have muscarinic receptors in brain with few nicotinic receptors
-Nicotine crosses the BBB (unlike muscarine) and stimulates release of serotonin, dopamine, GABA, NE

NMJ:
-Immediate depolarization of the end plate
-Increased permeability to Na+ and K+
-Muscle contraction, and if not hydrolyzed immediately, depolariation blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Use of Cholinomimetic Agonists

Two categories of them?

A

These drugs mimic the effects of ACh and are broken down into two categories:
ACh stimulants or cholinesterase inibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Examples of them

Directing acting cholinomimetic agents; alkaloids

A

-Act directly on the nACh-r or mACh-r.
-Considered stimulants

Alkaloids: Plant based
-Muscarine: Activates PNS system
-Nicotine: Stimulates nACh-r
-Pilocarpine, lobelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Examples of them

Directing acting cholinomimetic agents; Esters of choline

A

-Act directly on nACh-r or mACh-r
-Not lipid soluble, permanently charged
-ACh: Used primarily for pupil dilation, but we have better drugs
-Methacholine: Dx of asthma
-Succinylcholine: Paralytic
-Carbachol: Decrease intraocular pressure
-Bethanecol: Bladder dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Examples of them, uses for them, 3 classes of them

Indirect acting cholinomimetic (Cholinesterase Inhibitors)

A

-Carbamates:
Neostigmine- Post Op ileus, MG
Pyridostigmine- MG

-Alcohols:
Edrophonium: Dx for MG

-Organophosphates:
Echothiopate: Glaucoma, lasts over 100 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Difference between Nicotinic and Muscarinic Receptors
Ionotropic vs Metabotropic

A

Nicotinic: Ligand gated ion channels (ionotropic)
Muscarinic: metabotropic GPCR channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How does atropine effect this?

Open-Angle & Narrow-Angle Glaucoma

A

In general, the iris of the eye is flat in comparison to the cornea. This allows aqueuos drainage to pass through the Canal of Schlemm.
In open-angle glaucoma, we can use cholinomimetics to contrict the pupil, widening the angle, allowing for more drainage to pass, and decrease intraocular pressure. Open-angle glaucoma makes up for about 90% of glaucoma cases

In narrow-angle glaucoma, the iris is being pushed forward towards the pupil. The Canal of Schlemm is very narrow because of this. Giving atropine to dilate the pupil, in this situation, would occlude the canal of schlemm and could result in blindness. This is a medical emergency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

S/S, Tx

Organophosphate pesticide poisoning & Poisonous mushrooms

A

-SLUDGE-M

Organophosphates:
-Tx: Vital sign maintenance, decontamination, atropine or pralidoxime (must be given withint the first couple of hours)

Mushrooms:
Atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Antimuscarinic Drugs
4 of them we need to know for class

A

-Atropine (bradycardia)
-Scopalamine (Motion Sickness)
-Tropicamide (eye)
-Ipratropium (COPD)

-MOA: Blocks mACh-r
-Block PNS effects

-Eye indications: Miosis (contraction of pupil), mydriasis (dilation of the pupil), paralysis of cilliary muscle (cycloplegia), accomodation (focus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

S/S, Tx

Nicotine Poisoning

A

-40mg is fatal dose. Usually happens if children eat cigarettes
-Tremor, vomitting, convulsions, fatal coma, and death
-Need to induce vomitting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Cholinesterase Inhibitors

Organophosphates MOA & Aging

A

Organophosphates target AChE. The organophosphate binds to the enzyme by hydrolysis and phosphorylation of the active site. A covalent bond is formed with the phosphorylated active site.

After the intial covalent bond is formed, the aging process begins; meaning, the phosphorous-active site bond continues to become stronger and irreversible

Pralidoxime needs to be given immediately, before aging progresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Antimuscarinic Effects on Major Organ Systems

A

Eye:
-Dilation, decreased watering (via paralysis of the cilliary muscle)
Heart:
Increased HR
Misc: Decreases salivation, decreases rate at which urine is produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Atropine Toxicity & Treatment

A

Belladona plant or deadly nightshade
-Tachycardia, agitation, increased body temperature, dilated pupils, decreased salivation and sweat, dry skin
-These symptoms can be overcome by increasing the amount of ACh in the synapse.
-Physostigmine (dangerous CNS side effects), Neostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Indications & Contraindications for Atropine

A

Indications: Overproduction of PNS response, parkison’s, poisonous mushroom toxicity
Used to block toxic effects of muscarinic stimulants; use atropine if SLUDGE-M

Contraindicated in narrow-angle glaucoma, BPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Nicotinic Antagonists: Depolarizing and non-depolarizing muscle relaxants

And ganglion blockers

A

-Do not use ganglion blockers anymore; their role was to block the release of ACh
-Depolarizing: Succinylcholine; mimics two ACh molecules. Binds to the nACh-r in place of ACh, depolarizes the muscle. Muscle remains depolarized locally at the skeletal muscle end plate

Nondepolarizing: Block ACh from binding. Only need one to bind.
Long acting- pancuronium
Intermediate- Atracurium
Short- Mivacurium

Reversed by neostigmine (increases ACh at the NMJ) or sugammadex (encapsulates the paralytic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Basic Structure of Catecholamines & How Substitutions Affect Degradation

Non-catecholamines & alpha carbon

A

-Benzene ring with adjacent hydroxyl groups (cathechol) and an amine group
-Substitution greatly reduces potency
-Cannot be taken PO, inactivated immediately by cOMT in gut
-Catecholamines are degraded by catechol-O-methyltransferase (COMT)

Drugs such as Phenylephrine (no catechol group) cannot be degraded by COMT
-Longer half-lives
-Increased lipid solubility
-Increased PO bioavailability

Substitution at Alpha Carbon (2nd carbon):
-Prolonged action
-Not broken down as quickly by monoamine oxidase (MAO)
Ex: Phenylephrine, ephedrine, amphetamine

41
Q

MOA of indirect & direct acting catecholamines

A

Indirect agonists: Cause the release of the catecholamines
-Ephedrine, Amphetamine
Direct Agonists: Stimulate the adrenoreceptor directly

42
Q

Epinephrine

A

-Mixed Adrenergic Agonist
-Binds to A1, A2 (some), B1, B2
-Increases PVR, CO (HR, SV), BP
-B2 vasodilates blood vessels in skeletal muscles, dilation of bronchioles

43
Q

Phenylephrine/Midodrine

A

-Pure A1 agonist
-Increases PVR
-Can cause decrease in CO
-Reflex bradycardia immediately after given
-Decongestant if given PO

Midodrine- pure A1 agonist
-Decreases orthostatic HTN, can cause HTN in supine patient

44
Q

Isoproterenol

A

-Beta 1 & 2 agonist
-Increases HR, contraction, CO, SV
-Decreases PVR, can cause decrease in BP

45
Q

Dopamine

A

-Dose dependent
-Low dose (0.3mcg/ml or less): D1 receptors in kidneys; Induces diuresis
-Intermediate Dose (0.3mcg-0.7mcg): Beta 1
-High dose (>1mg/ml): A1 agonist. Increases the work of the heart, can induce arrythmias

46
Q

Norepinephrine

A

-A1, A2, B1 agonist
-Increases both SBP and DBP
-Hardly any B2 activity

47
Q

Dobutamine

A

-B1 Selecive Agonist
-Cardiogenic shock, CHF exacerbation

48
Q

Ephedrine

A

-Indirect acting; releases stored catecholamines
-Direc acting; acts as epinephrine, crosses BBB
-PO pseudoephedrine

49
Q

What Questions Should We Ask When Picking a Sympathomimetic?

A

-Which receptor activation is required?
-Route of administration
-Dosing and monitoring therapeutic dose

50
Q

Sympathomimetic Toxicity

Adrenergic Agonists

A

-Effects seen are a direct extension of their receptor effects
-HTN
-Cerebral hemorrhage
-Pulmonary edema
-Angina
-Cardiac tamponade
-MI
CNS toxicity- convulsions

51
Q

Alpha Blockers

MOA? BP? HR? Drug ex

A

-Decrease PVR, reducing preload & blood pressure
-Should have no direct effect on HR

-Nonselective uses for alpha blockers: Useful in tx for pheochromocytoma

Phentolamine, Phenoxybenzamine, and then typically end in
“-osin”
If it ends in “-zosin”–> BPH

52
Q

Phentolamine

Reversible or not?

A

Competitive antagonist of A1 & A2
-Reduces PVR
-Causes some cardiac stimulation
-Minor agonist of muscarinic and histamine receptors

Adverse Effects:
Cardiac stimulation (M-r in heart, can increase HR)
Abdominal pain, N/V/D

Used for treatment of HTN linked to pheochromocytoma
ED- direct injections

53
Q

Phenoxybenzamine

Reversible or not?

A

-Mostly selective for A1
-Forms covalent bonds, non-competitive, insurmountable
-Inhibits NE reuptake, blocks H1, ACh, and Serotonin receptors
-

54
Q

Beta Blockers

Propranolol, Metoprolol, Atenolol, Esmo, Labeta, and indications

A

-Propranolol is the prototype:
-Extensive first pass
-Non Selective, B1 and B2

Metoprolol, Atenolol:
Mainly B1 selectivity
Safer in COPD and diabetics

Esmolol:
Ultra short acting
Selective for B1
Safer in critically ill, fast on fast off

Labetalol:
Racemic mixture
S,R isomer is a1 blocker
R,R isomer is a B blocker

55
Q

Regulators of BP, 3 factors in PVR

Hydraulic equation, PVR, CO, Volume,

A

-Hydraulic Equation - BP = CP x PVR

Factors that affect BP:
PVR
Vessel elasticity
Blood volume
CO (HR x SV)

PVR is hard to measure. Three factors in PVR
1. Blood vessel diameter
2. Blood Viscosity
3. Total Vessel length

56
Q

Four anatomic control sites for BP

A
  1. Arterioles: Provide resistance
  2. Venules: Increase return to the heart, contributes to preload
  3. Heart: CO
  4. Kidneys: Volume regulation via RAAS
57
Q

Categories of Anti-HTN Agents

Act on one or more of the anatomic control sites

A
  1. Diuretics (Lasix, Bumex, HCTZ): Deplete Na+
  2. Sympathoplegics (Alpha & Beta blockers): Decrease PVR, reduce CO
  3. Direct vasodilators: Relax vascular smooth muscle
  4. Anti- Angiotensins: Block activity or production of
58
Q

Clonidine & Precedex

Targets, Effects, Indications for use, major side effects

A

-Targets vasomotor center in CNS
-A2 agonist
-Primary activity is due to inhibition of sympathetic outflow and increased parasympathetic outflow in brainstem
-Crosses BBB, enters rapidly
-Side effect is sedation, used as anesthesia adjunct as well as

Clonidine is primarily used for ADHD, tourettes, w/d symptoms

59
Q

Methyldopa

Targets, effects, indications, side effects

A

-Target is vasomotor center in the CNS
-Analog of L-dopa
-Prodrug; works by replacing NE and decreasing NE release
-Does not cross placental barrier
-Does cross BBB
-Primary use for pregnancy- induced HTN
-S/E sedation

60
Q

Yohimbine

A

Alpha 2 Antagonist
Does not work
We don’t use it

61
Q

Vasodilators

MOA

A

-Relax smooth muscle of arterioles (all vasodilators) and veins (nitroprusside & nitrates)
-Reduces MAP and PVR
-Elicits compensatory responses- RAAS system, so best when given in conjuction with anti-HTN that combat these responses

62
Q

Vasodilators

Minoxidil

MOA

A

-Opens K+ channels in smooth muscle, hyperpolarizing membrane potential, less likely to contract
-Dilates arteries and arterioles

-Rogaine

63
Q

Vasodilators

Hydralazine

MOA, toxicity

A

Dilates arterioles–> possibly NO production?
-Toxicity includes: HA, N, sweating, flushed. Symptoms are similary to lupus

64
Q

Vasodilators

Sodium Nitroprusside

MOA, indictions, toxicity

A

-Relaxes venous and arterial smooth muscle by releasing NO
-Rapidly lowers BP
-Protect from light
-HTN emergencies and heart failure

-Breaks down into cyanide, begins to accumulate >48hours.
Can cause metabolic acidosis, arrythmias, death
Need to give sodium thiosulfate to metabolize CN

65
Q

Three Classes of CCB & their targets

A

-Verapamil: Targets the heart
-Diltiazem: Targets heart and peripheral vasc
-Dihydropyridine blockers: end in -dipine, target the peripheral vasc

66
Q

RAAS System

A

Low BP detected by kidneys –> Angiotensinogen (an inactive precurse made by the liver) is converted by renin into Angiotensin I–> Angiotensin I is converted into Angiotensin II by ACE which leads to:
1. Vasocontriction in the blood vessels
2. Aldoseterone release causing increased Na+ & water retention

67
Q

ACE Inhibitors & ARBS

MOA, drug name ending

A

Ace Inhibitors: By blocking ACE, we stop the conversion from Angiotensin I to Angiotensin II
This also inhibits the breakdown of bradykinins, leading to increased inflammation in the lungs –> dry hacking cough as side effect

Ace inhibitors end in -pril

ARBs block the angiotensin II receptors in the blood vessels and adrenal cortex

Arbs end in -sartan

68
Q

Pulmonary HTN

A
  • In the lungs, ET-1 binds to both ET-A and ET-B in the presence of things such as AngII, cytokines, thrombin. When bound, ET-A, ET-B both cause vasoconstriction and proliferation of smooth muscle cells
  • -Causes: High systemic BP, congenital, COPD, heart failure
    -Tx: In the hospital, can use IV prostaglandins to induce pulmonary vessel vasodilation; epoprostanol

At home, can use endothelin receptor antagonists: Bosenten, Tezosentan

69
Q

HTN Urgency & HTN Crisis

A

HTN Urgency: >180/110 w/o acute end organ damage. Need to lower BP in hours

HTN Crisis: >180/110 w/ acute end organe damage (stroke, AKI). Need to be treated in the ICU with immediate lowering of BP

70
Q

Tx for mild, moderate, and emergent HTN

A

Mild: Decrease Na+ intake, exercise, weight reduction in obese patients. Evaluate whether taking decongestants, NSAIDS, contraceptives, ETOH

Moderate: Meds, will often need a combination

Emergent: IV meds

71
Q

Differences in arterial, venous, and capillary tone

A

-Arterial: Consists of arteries and arterioles. Much more forceful than venous tone (16x more forceful in artery)

-Venous tone: Much larger capacitance that arteries. This allows the venous system to function as a reservoir for blood volume and circulate blood volume back to the heart

-Capillary tone: none

72
Q

Pathophysiology of stable angina, vasospastic angina, unstable angina

A

-Stable/Angina of Effort: Accumulation of metabolites. O2 requirement increases due to exercise or symapthetic stimulation, and those increased O2 demands are not met because blood flow does not increase proportionally

-Vasospastic/Prinzmetal: O2 delivery decreased due to coronary vasospams

-Unstable angina: Angina at rest; usually due to atherosclerotic plaque

73
Q

Coronary blood flow is…

A

Directly related to perfusion pressure (DBP) and the duration of diastole
Coronary vessels are not perfused during systole

74
Q

Drugs & Interventions to relieve chest pain

A

Stable Angina: Reduction of aggravating factor/demand. If HTN, CCB & beta blockers. Non-HTN, nitrates. pFox inhibitors

Vasospastic: Potent vasodilators. Nitrates or CCBs

Unstable: Medical emergency. PCI, stent placement, CABG

75
Q

CCB Vascular tone reduction pathway

A

-Blocks Ca++ channel–> Ca++ cannot flux into the cell–> this leads to a direct decrease in calmodulin activity –> inhibiting myosin light chain kinase –> preventing contraction

76
Q

K+ Channel Blockers & Effect on vascular tone

A

-Causes K+ to leave the cell, hyperpolarizing the cell, making it more difficult to depolarize

77
Q

Nitrates/ Nitrites

A

-NO occurs naturally in the body, produced by vascular endothelial cells
-Blood flow against the vascular endothelium cause the release of Ca+ which activates NO synthase
-NO synthase converts L-Arginine into NO
-NO activates the enzyme guanylyl cyclase, found in vascular smooth muscle
-Guanylyl cyclase catalyzes the dephosphorylation of GTP to cGMP–> causes smooth muscle relaxation
1. Inhibits Ca+ entry into cell
2. Increases uptake of Ca+ into endoplasmic reticulum

Increase venous capacitance, decrease ventricular preload, decrease CO output
Can cause reflex tachycardiac, orthostatic hypotension
Methhemoglobin

78
Q

Drug classes that reduce vascular tone

A

NO, Nitrates, Nitrites- MOA on other flashcard

Beta-2 Agonists- Increases cAMP in pulmonary vessels –> relaxation here

CCB: Block Ca++ channel, leading to decreased contraction

Sildenafil: PDE inhibitor–> leads to increase in cGMP –> relaxation of vascular smooth muscle

79
Q

Heart Failure:
Systolic vs Diastolic

A

Systolic: Thin, floppy ventricles. Causes decreased cardiac output, decreased EJ
Diastolic: Thick, muscular ventricles. Unable to relax to allow to diastolic filling. Decreased CO, normal EJ

80
Q

Congestive Heart Failure; L vs R

A

Left heart: Increased left ventricular pressure at the end of diastole. This causes pulmonary congestion.

Right heart: Blood can backup into R IJ, hepatic vein

81
Q

Normal Cardiac Function; how does Ca++ interact with myocites to allow contraction?

A

-Ca++ enters the cell through a Ca++ channel. That Ca++ (referred to as the ‘“trigger” Ca++) interacts with the Ca++ release channel on the wall of the sarcoplasmic reticulum –> stored Ca++ is released into the cytoplasm, allowing for actin to interact with myosin –> one heart bear

82
Q

Four Factors of Cardiac Performance; and how they are altered in heart failure

A
  1. Preload: This is our EDP; however, often synonymous with EDV. Decreased in diastolic HF, increased in systolic HF
  2. Afterload: Resistance in which the heart must pump against. Increases as CO decreases (compensatory)
  3. Contractility: The force with which the heart contracts. Very poor in systolic HF. Too forceful in diastolic HF
  4. Heart Rate: Main determinant of CO. First compensatory mechanism to respond to decreased CO. Lowering HR in diastolic HF will allow for more filling time
83
Q

Frank Starling Law

A

Strength of contraction increases the more the heart stretches (to a certain point)

84
Q

What contributes to EDV?

Three things

A

Passive filling+ atrial contraction + ESV

85
Q

Strategies and drugs to tx HF

Correcting Failure of Cardiac Contractility

A

-Positive Inotropes: Cardiac glycosides; digoxin

-Phospodiesterase Inhibitors: indirectly increase inotropy by inactivating cAMP and cGMP (milrinone)

-Beta adreneric stimulants: Dopamine & Dobutamine

-Ca++ sensitizers: Positive Inotropy & vasodilations

86
Q

Strategies and drugs to tx HF

Reversing Salt and Water Retention

A

-Diuretics: Reduce preload, reduce edema, reduce cardiac size, and improve efficiency of cardiac pump

87
Q

Strategies and drugs to tx HF

Unloading stress on the myocardium

A

-Reduce compensatory mechanisms in response to HF (RAAS); Ace inhibitors- captopril

-ARBS: Losartan

-Vasodilators: reducing preload and afterload

88
Q

ADME

Digoxin

MOA & Toxicity, electrolytes, what do we see on EKG?

A

Inhibits the Na+, K+, ATPase pump on the heart and is a positive inotrope. Increases PR interval, decreases QT interval

Has a narrow therapeutic index. Toxic doses can cause tachycardia, a fib, v fib, and cardiac arrest.
Toxic doses also produce oscillatory after-depolarizations, increasing risk for v-fib and v-tach.

Hyperkalemia: K+ competes with dig
Hypercalcemia & hypomagnesium: Increased risk of arrhythmias

EKG- downward schwoop after QRS

Well absorbed, distributed widely in tissues and CNS
T1/2 36-40hrs
2/3 excreted unchanged in the kidneys

89
Q

Non-pharmaceutical interventions for HF

A

-LVAD
-Chronic biventricular resynchronization
-Defibrillatory
-Heart transplant
-End stage: hospice

90
Q

Intrinsic Conduction System/Pathway

A

SA node –> enforces a contraction rate of 110bpm –> AV node, located in the junction of the atria and ventricles, slows down the rate of conduction to ~75bpm
Conduction travels from the AV node down the Bundle of His –> down the left and right purkinje fibers

91
Q

Conduction and how it correlates to a normal EKG

A

P-Q interval is atrial depolarization
QRS complex is ventricular depolarization
ST segment is ventricular depolarization

92
Q

Cardiac Action Potential, Phases & Ion Movement

A

Phase 0: Depolarization of cardiac cells; action potential upstroke. AP is “over-shot” just a litte. Na+ moves in

Phase 1: K+ begins to leave the cell, membrane potential decreases slightly

Phase 2: K+ still leaving; however, Ca++ enters the cell, prolonging the action potential to allow the heart to pump

Phase 3: K+ leaving the cell, repolarization

Phase 4: Vrm

93
Q

Main Classifications of Arrhythmias; Disturbances in impulse formation

A

Disturbances in impulse formation:
-SA/AV nodal abnormalities
-Ion changes
-SNS stimulation

  1. Vagal Discharge: Slows the HR, hyperpolarizes the cell. Reduction in phase 4 slope
  2. Acceleration of HR caused by beta agonists, fiber stretch, or acidosis.
    Will see an increase in phase 4
94
Q

Main Classifications of Arrhythmias; Disturbances in impulse conduction

A

Disturbances in impulse conduction:
-1st degree, 2nd degree (Type I & II), 3rd degree block

-Re-entry:
-Block is unidirectional, there must be an obstacle (scar tissue), and conduction time must be long enough to reenter same areas after refractory period

95
Q

Antiarrhythmic Agents-Four Classes

A

Class I: Sodium channel blockade
Class II: Sympatholytic (beta blockers)
Class III: Prolong action potential duration, K+ channels
Class IV: CCB

96
Q

Antiarrhythmic Agents- Class IA, IB, IC

A

IA: Sodium channel blocker
-Procainimide, Quinidine
-Prolongs action potential duration and increases effective refractory period

IB: Sodium channel blocker
-Lidocaine, Mexiltine
-Shortens APD, decreases ERP

IC
-Flecainide, Propafenone
-Minimal effects on APD, no effect on ERP

97
Q

Antiarrhythmic Agents- Class III

A

Amiodarone- prolongs cardiac action potential, dilation in peripheral vasculature

Toxicity: Bradycardia or heart block, precipitate heart failure, fatal pulmonary fibrosis, concentration in tissues

98
Q

Antiarrhythmic Agents- Class IV

A

Verapamil; CCB
-Blocks inactivated and activated Ca++ channels
-Prolongs AV node conduction
-Slows SA node
-Can cause hypotension

99
Q

Adenosine

A

Enhances K+ conductance
Inhibits cAMP induced Ca++ influx
T1/2: ~10seconds